Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Indivior Pharmaceuticals, Inc. (INDV) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Indivior Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1625297.
Total stock buying since 2026: $172,397.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 4,871 | $172,397 | 0 | $0 | 292,696 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-03 | 0 | $0 | 0 | $0 | 292,696 | $0 |
| 2026-01 | 4,871 | $172,397 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-03 | Preblick Ryan (Chief Financial Officer) | Option Ex | 86,949 | .00 | 0 |
| 2026-03-03 | Heidbreder Christian (Chief Scientific Officer) | Option Ex | 101,544 | .00 | 0 |
| 2026-03-03 | Anderson Woodrow D (Chief Accounting Officer) | Option Ex | 24,310 | .00 | 0 |
| 2026-03-03 | Burris Jeffrey W (Chief Legal Officer) | Option Ex | 79,893 | .00 | 0 |
| 2026-01-05 | Humphreys Keith (Director) | Buy | 775 | 35.39 | 27,429 |
| 2026-01-05 | Ryan Barbara (Director) | Buy | 775 | 35.39 | 27,429 |
| 2026-01-05 | Wheadon David E. (Director) | Buy | 1,771 | 35.39 | 62,681 |
| 2026-01-05 | Stejbach Mark (Director) | Buy | 775 | 35.39 | 27,429 |
| 2026-01-05 | Ninivaggi Daniel A (Director) | Buy | 775 | 35.39 | 27,429 |
Insider trading activities including stock purchases, stock sales, and option exercises of INDV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Indivior Pharmaceuticals, Inc. (symbol INDV, CIK number 1625297) see the Securities and Exchange Commission (SEC) website.